Project Grant R43AG092067
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research program) provides $1,998,535 to Pascall Systems, Inc. to commercialize their neuroscience-based EEG-guided precision anesthesia management system. The key products and services being delivered include: Pilot study to determine sample size, cost, and timeline for a Phase III multi-site clinical trial to optimize workflows, outcome measures, and caregiver protocol adherence for the Pascall M1 device....
- This $114,498 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study to investigate the construct validity of smartwatch-derived metrics for early detection of Alzheimer's disease and related dementias. The study will recruit a diverse sample of 90 participants aged 55 and older with healthy cognition or mild cognitive impairment from the Philadelphia region. Participants will wear a Garmin Vivosmart 4 smartwatch for 30 days to passively monitor...
- The National Institute on Aging (NIA) awarded a $499,993 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Applied Universal Dynamics, Corp to develop the SoundMind Smart Amplifier. The SoundMind Smart Amplifier is an affordable, accessible, and user-friendly hearing solution designed for older adults with both hearing loss and memory concerns. The project aims to create an amplifier that enhances speech audibility, reduces cognitive listening effort, and improves...
- This Project Grant award of $499,943 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), supports the development of a novel, unobtrusive device by Aster Labs, Inc. to continuously measure and analyze gait patterns in older Black adults as an early indicator of health decline from Alzheimer's disease and related dementias (ADRD). The device aims to provide medical professionals and caregivers with remote access to these insights to help...
- This Project Grant award of $1,006,653 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Posit Science Corp. supports the "IMPROVING NEUROLOGICAL HEALTH WITH ACETYLCHOLINE VIA NEUROPLASTICITY-BASED COMPUTERIZED EXERCISE IN MILD COGNITIVE IMPAIRMENT (INHANCE-MCI)" program. The project aims to deploy a computerized cognitive training program that integrates validated exercises to potentially reduce the long-term risk of dementia onset in individuals with mild...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $506,399 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to Healthy Design LTD. CO. to develop a novel continuous predictive wearable agitation monitor and alert system using actigraphy and AI for hospitalized older adults. The goal is to prevent delirium and dementia by closely monitoring agitation levels and enabling timely implementation of non-harmful...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $499,686 to support the development of the Momento smartphone app. The app aims to transform regular photo activities into a way to continuously monitor cognitive function and detect early signs of memory changes in older adults. Key goals of the 1-year project include: 1) Testing how 200 older adults use and enjoy the app, ensuring it is engaging for regular use; and 2) Verifying the system can...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
- This Project Grant award of $343,350, provided by the National Institute on Aging (NIA, CFDA 93.866 Aging Research), supports research to investigate the neurocomputational mechanisms underlying age-related deficits in visual perception. The project aims to examine the role of alpha-gamma neural oscillations in deteriorating contrast sensitivity and 3D structure-from-motion perception, which significantly impact the health and quality of life of aging adults. Employing functional and...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $250,812 Project Grant to Rubato, Inc. to develop and validate a protocol for a biometrically-tailored, AI-driven music-based intervention (MBI) to reduce behavioral and psychological symptoms of dementia (BPSD) in people living with Alzheimer's disease and related dementias. The 2-year project, running from August 2025 to May 2027, will enhance the existing Rubato MBI to include...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $467,538 to Oscilloscape, Inc. (dba Oscillo Biosciences) to develop and test an innovative, wearable digital health device called "SYNG" to help aging adults with Alzheimer's disease and mild cognitive impairment. The device aims to deliver a digital therapy using music and synchronized visual brain stimulation to restore healthy brain rhythms through neural entrainment. Key outcomes of the project include creating a wearable version of the device and conducting an IRB-approved study to assess the necessary dosage level for a therapeutic neural response. Oscilloscape has collaborated with Northeastern University, receiving sub-grants for related projects such as developing adaptive neural network-controlled visual stimulation devices and investigating gamma-music based interventions for mild Alzheimer's disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $467.5k | 9/18/25 |